BioPharma Credit

BioPharma Credit plc provides investors with an opportunity to gain exposure to the fast growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. BioPharma Credit’s primary objective is to generate predictable income for shareholders over the long term.

Company Members

Articles Featuring BioPharma Credit

Biotech debt fund breaches $1bn

13th April 2018 | Daniel Lanyon

Biotech turns to Alternative Credit in new fund

29th March 2017 | Daniel Lanyon